Boehringer Ingelheim hands expanded remit to krow Group

Boehringer-Ingelheim-Pet

Full-service creative communications agency, krow Group, has been appointed by pharma company, Boehringer Ingelheim Pet, across seven new brands and three new franchises.

Krow said the expanded remit, which came following a competitive pitch, strengthens the existing relationship between the two companies.

Boehringer Ingelheim Pet

The recent wins, which include Metacam, Vetmedin and Senvelgo, see krow Group expand into the vet prescription medicine category.

Bolstering krow Group’s remit within the animal health arm of the pharmacist firm, the agency has been tasked with delivering activity from top-level strategy through to activation.

Krow Group has worked on the retail side with Boehringer Ingelheim’s FRONTLINE portfolio for over 25 years.

Abi Butler, Head of Pet Marketing at Boehringer Ingelheim, said: “We have been really impressed with the work krow Group has delivered to date and after a rigorous pitching process it made sense to widen their remit and bring them onboard for our next chapter.”

John Quarrey, CEO at krow Group, said: “Having the opportunity to be involved with more brands and franchises within Boehringer Ingelheim is a brilliant opportunity.

“Their commitment to innovation is something we align with and we’re proud to be their partner as they continue to expand.”

Founded in 1885, Boehringer Ingelheim is one of the world’s largest pharmaceutical companies, and the largest private one.

Headquartered in Ingelheim, it operates globally with 146 affiliates and more than 47,700 employees.